Teva Pharmaceutical Industries Limited Peer Comparison
Metric | Value | Ranking | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $18.4 Billion | 3/13 | ZTS $70.5B |
TAK $42.9B |
TEVA $18.4B |
VTRS $12.9B |
CTLT $11.5B |
ELAN $5.6B |
BHC $2.3B |
TLRY $872.0M |
CRON $753.1M |
SNDL $493.8M |
ACB $346.3M |
CGC $320.5M |
HEXO $31.2M |
Gross Margin | 50% | 4/13 | BHC 99% |
ZTS 69% |
TAK 66% |
TEVA 50% |
ELAN 39% |
VTRS 39% |
ACB 33% |
CGC 30% |
TLRY 29% |
SNDL 27% |
CTLT 18% |
CRON 8% |
HEXO -43% |
Profit Margin | -5% | 7/13 | ELAN 35% |
ZTS 25% |
CRON 18% |
TAK 8% |
VTRS 3% |
BHC -3% |
TEVA -5% |
SNDL -8% |
CTLT -13% |
ACB -38% |
TLRY -40% |
CGC -100% |
HEXO -100% |
EBITDA margin | 6% | 5/13 | ZTS 39% |
TAK 32% |
BHC 13% |
CRON 12% |
TEVA 6% |
VTRS 6% |
CTLT 5% |
ELAN 0% |
SNDL -1% |
ACB -3% |
TLRY -20% |
CGC -62% |
HEXO -137% |
Quarterly Revenue | $4.2 Billion | 2/13 | TAK $8.2B |
TEVA $4.2B |
VTRS $3.7B |
BHC $2.5B |
ZTS $2.3B |
ELAN $1.0B |
CTLT $1.0B |
TLRY $211.0M |
SNDL $178.1M |
CGC $74.0M |
ACB $56.5M |
CRON $46.6M |
HEXO $16.2M |
Quarterly Earnings | -$217.0 Million | 13/13 | TAK $644.1M |
ZTS $581.0M |
ELAN $364.0M |
VTRS $94.8M |
CRON $8.3M |
SNDL -$14.5M |
ACB -$21.3M |
BHC -$85.0M |
TLRY -$85.3M |
HEXO -$88.1M |
CGC -$128.3M |
CTLT -$129.0M |
TEVA -$217.0M |
Quarterly Free Cash Flow | $446.0 Million | 4/13 | TAK $1.3B |
VTRS $750.5M |
ZTS $689.0M |
TEVA $446.0M |
BHC $341.8M |
ELAN $120.0M |
SNDL $14.0M |
CTLT $4.0M |
CRON -$0 |
HEXO -$407,519 |
TLRY -$40.7M |
CGC -$71.4M |
ACB -$0 |
Trailing 4 Quarters Revenue | $16.5 Billion | 2/13 | TAK $31.8B |
TEVA $16.5B |
VTRS $15.0B |
BHC $9.5B |
ZTS $9.3B |
ELAN $4.5B |
CTLT $4.4B |
SNDL $685.1M |
TLRY $671.3M |
CGC $371.4M |
CRON $146.7M |
ACB $139.9M |
HEXO $93.3M |
Trailing 4 Quarters Earnings | -$1.6 Billion | 13/13 | TAK $8.2B |
TEVA $4.2B |
VTRS $3.7B |
BHC $2.5B |
ZTS $2.3B |
ELAN $1.0B |
CTLT $1.0B |
TLRY $211.0M |
SNDL $178.1M |
CGC $74.0M |
ACB $56.5M |
CRON $46.6M |
HEXO $16.2M |
Quarterly Earnings Growth | -147% | 12/13 | CRON 608% |
TAK 292% |
ELAN 133% |
ACB 95% |
CTLT 82% |
BHC 78% |
HEXO 19% |
ZTS 11% |
SNDL 11% |
VTRS -71% |
TLRY -85% |
TEVA -147% |
CGC -57740% |
Annual Earnings Growth | -334% | 13/13 | BHC 185% |
ELAN 115% |
ACB 96% |
HEXO 88% |
CGC 83% |
CTLT 58% |
TAK 32% |
ZTS 7% |
SNDL 7% |
TLRY -2% |
CRON -77% |
VTRS -179% |
TEVA -334% |
Quarterly Revenue Growth | -5% | 11/13 | CGC 56634% |
ACB 50% |
CRON 37% |
TAK 13% |
BHC 12% |
TLRY 9% |
ZTS 5% |
CTLT 4% |
SNDL 0% |
ELAN -4% |
TEVA -5% |
VTRS -5% |
HEXO -53% |
Annual Revenue Growth | 3% | 8/13 | CRON 61% |
CGC 12% |
BHC 8% |
TAK 8% |
ZTS 7% |
CTLT 6% |
ELAN 5% |
TEVA 3% |
VTRS -4% |
SNDL -6% |
TLRY -7% |
ACB -8% |
HEXO -39% |
Cash On Hand | $3.3 Billion | 2/13 | TAK $6.0B |
TEVA $3.3B |
ZTS $2.0B |
VTRS $1.9B |
CRON $862.0M |
BHC $719.0M |
ELAN $490.0M |
CTLT $335.0M |
CGC $228.4M |
SNDL $197.7M |
TLRY $189.7M |
ACB $118.7M |
HEXO $15.0M |
Short Term Debt | $1.8 Billion | 2/13 | TAK $4.4B |
TEVA $1.8B |
VTRS $1.4B |
ZTS $1.4B |
BHC $453.0M |
CGC $137.9M |
HEXO $134.4M |
CTLT $61.0M |
ACB $59.7M |
ELAN $44.0M |
TLRY $40.2M |
SNDL $26.0M |
CRON $980,000 |
Long Term Debt | $16.3 Billion | 3/13 | TAK $31.0B |
BHC $21.1B |
TEVA $16.3B |
VTRS $16.2B |
ZTS $5.4B |
CTLT $4.9B |
ELAN $4.3B |
CGC $415.9M |
TLRY $333.6M |
SNDL $92.5M |
ACB $57.8M |
CRON $872,000 |
HEXO $797,744 |
PE | -1.00 | 5/13 | ZTS 28.37 |
ELAN 27.13 |
TAK 21.15 |
BHC 8.84 |
TEVA -1.00 |
CRON -1.00 |
CTLT -1.00 |
ACB -1.00 |
CGC -1.00 |
HEXO -1.00 |
SNDL -1.00 |
TLRY -1.00 |
VTRS -1.00 |
PS | 1.11 | 8/13 | TAK 192.82 |
ZTS 7.62 |
CRON 5.13 |
ACB 3.29 |
CTLT 2.60 |
TLRY 1.30 |
ELAN 1.25 |
TEVA 1.11 |
SNDL 0.96 |
CGC 0.86 |
VTRS 0.86 |
HEXO 0.45 |
BHC 0.24 |
PB | 3.22 | 3/13 | ZTS 14.79 |
CTLT 3.25 |
TEVA 3.22 |
ACB 0.91 |
TAK 0.89 |
ELAN 0.85 |
CRON 0.67 |
VTRS 0.65 |
CGC 0.63 |
SNDL 0.54 |
HEXO 0.29 |
TLRY 0.25 |
BHC 0.00 |
PC | 5.58 | 6/13 | ZTS 35.53 |
CTLT 34.40 |
ELAN 11.35 |
TAK 7.14 |
VTRS 6.86 |
TEVA 5.58 |
TLRY 4.60 |
BHC 3.15 |
ACB 2.92 |
SNDL 2.50 |
HEXO 2.08 |
CGC 1.40 |
CRON 0.87 |
Liabilities to Equity | 6.25 | 1/13 | TEVA 6.25 |
ZTS 1.98 |
HEXO 1.78 |
CTLT 1.74 |
CGC 1.42 |
VTRS 1.26 |
TAK 1.11 |
ELAN 1.04 |
ACB 0.68 |
TLRY 0.21 |
SNDL 0.18 |
CRON 0.05 |
BHC 0.00 |
ROA | -0.04 | 6/13 | ZTS 17% | ELAN 2% | BHC 1% | TAK 0% | VTRS -2% | TEVA -4% | CRON -4% | CTLT -4% | TLRY -5% | SNDL -6% | ACB -13% | HEXO -52% | CGC -88% |
ROE | -0.30 | 11/13 | ZTS 52% |
ELAN 3% |
TAK 0% |
CRON -4% |
VTRS -4% |
TLRY -6% |
SNDL -7% |
CTLT -12% |
BHC -22% |
ACB -23% |
TEVA -30% |
HEXO -144% |
CGC -212% |
Current Ratio | 1.17 | 12/13 | CRON 22.42 |
SNDL 6.60 |
TLRY 5.68 |
ACB 2.57 |
ELAN 1.96 |
TAK 1.90 |
VTRS 1.79 |
CGC 1.71 |
CTLT 1.57 |
HEXO 1.56 |
ZTS 1.50 |
TEVA 1.17 |
BHC 0.99 |
Quick Ratio | 0.10 | 8/13 | ZTS 28.37 |
ELAN 27.13 |
TAK 21.15 |
BHC 8.84 |
TEVA -1.00 |
CRON -1.00 |
CTLT -1.00 |
ACB -1.00 |
CGC -1.00 |
HEXO -1.00 |
SNDL -1.00 |
TLRY -1.00 |
VTRS -1.00 |
Long Term Debt to Equity | 3.03 | 1/13 | TEVA} 3.03 |
CTLT} 1.38 |
ZTS} 1.13 |
CGC} 0.82 |
VTRS} 0.82 |
ELAN} 0.66 |
TAK} 0.64 |
ACB} 0.16 |
SNDL} 0.10 |
TLRY} 0.10 |
HEXO} 0.01 |
CRON} 0.00 |
BHC} -17.93 |
Debt to Equity | 3.36 | 1/13 | TEVA 3.36 |
ZTS 1.41 |
CTLT 1.40 |
HEXO 1.26 |
CGC 1.09 |
VTRS 0.89 |
TAK 0.73 |
ELAN 0.67 |
ACB 0.33 |
SNDL 0.13 |
TLRY 0.11 |
CRON 0.00 |
BHC -18.32 |
Burn Rate | 2.51 | 4/13 | SNDL 9.36 |
ACB 3.57 |
TAK 2.58 |
TEVA 2.51 |
VTRS 2.06 |
TLRY 1.75 |
CGC 1.27 |
CTLT 0.99 |
BHC 0.69 |
HEXO 0.15 |
ELAN -2.71 |
ZTS -71.56 |
CRON -106.83 |
Cash to Cap | 0.18 | 8/13 | CRON 1.14 |
CGC 0.71 |
HEXO 0.48 |
SNDL 0.40 |
ACB 0.34 |
BHC 0.32 |
TLRY 0.22 |
TEVA 0.18 |
VTRS 0.15 |
TAK 0.14 |
ELAN 0.09 |
ZTS 0.03 |
CTLT 0.03 |
CCR | -2.06 | 11/13 | VTRS 7.92 |
TAK 2.05 |
ZTS 1.19 |
CGC 0.56 |
TLRY 0.48 |
ELAN 0.33 |
CRON 0.00 |
HEXO 0.00 |
CTLT -0.03 |
SNDL -0.97 |
TEVA -2.06 |
BHC -4.02 |
ACB |
EV to EBITDA | 127.22 | 2/13 | CTLT} 288.11 |
TEVA} 127.22 |
VTRS} 126.74 |
ZTS} 83.11 |
BHC} 72.50 |
TAK} 11.02 |
HEXO} -6.22 |
CGC} -14.06 |
CRON} -18.74 |
TLRY} -25.50 |
SNDL} -130.88 |
ACB} -132.10 |
ELAN} -1885.69 |
EV to Revenue | 2.01 | 6/13 | TAK 131.78 |
ZTS 8.13 |
CTLT 3.64 |
BHC 2.44 |
ELAN 2.12 |
TEVA 2.01 |
HEXO 1.96 |
VTRS 1.91 |
ACB 1.85 |
CGC 1.74 |
TLRY 1.57 |
SNDL 0.39 |
CRON -0.73 |